13/09/2017
Soliqua® 100/33 provided earlier blood sugar control than insulin glargine 100 units/mL
Sanofi has announced that in certain adults with type 2 diabetes, Soliqua® 100/33 (insulin glargine and lixisenatide injection, 100 units/mL and 33 mcg/mL) provided blood sugar control earlier and in more adults than those [...]
